These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 36232867)

  • 21. Connecting type 2 diabetes to Alzheimer's disease.
    De Felice FG
    Expert Rev Neurother; 2013 Dec; 13(12):1297-9. PubMed ID: 24236899
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diabetes mellitus and Alzheimer's disease].
    Salacz P; Csibri E
    Orv Hetil; 2011 Mar; 152(13):512-5. PubMed ID: 21398212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.
    Bhattamisra SK; Shin LY; Saad HIBM; Rao V; Candasamy M; Pandey M; Choudhury H
    CNS Neurol Disord Drug Targets; 2020; 19(3):174-183. PubMed ID: 32418534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.
    Salameh TS; Rhea EM; Banks WA; Hanson AJ
    Exp Biol Med (Maywood); 2016 Sep; 241(15):1676-83. PubMed ID: 27470930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences.
    Grillo CA; Woodruff JL; Macht VA; Reagan LP
    Exp Neurol; 2019 Aug; 318():71-77. PubMed ID: 31028829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin: an emerging treatment for Alzheimer's disease dementia?
    Morris JK; Burns JM
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):520-7. PubMed ID: 22791280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.
    Das S; Ramachandran AK; Halder D; Akbar S; Ahmed B; Joseph A
    CNS Neurol Disord Drug Targets; 2023; 22(7):973-993. PubMed ID: 35770411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.
    Cuperfain AB; Kennedy JL; Gonçalves VF
    Neurosci Biobehav Rev; 2020 Apr; 111():125-134. PubMed ID: 31978440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease.
    Patel V; Edison P
    J Neurol Neurosurg Psychiatry; 2024 May; 95(6):581-589. PubMed ID: 38290839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes Mellitus and Energy Dysmetabolism in Alzheimer's Disease: Understanding the Relationships and Potential Therapeutic Targets.
    Onaolapo AY; Ojo FO; Adeleye OO; Falade J; Onaolapo OJ
    Curr Diabetes Rev; 2023; 19(8):e020123212333. PubMed ID: 36593701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease.
    Jash K; Gondaliya P; Kirave P; Kulkarni B; Sunkaria A; Kalia K
    Drug Dev Res; 2020 Apr; 81(2):144-164. PubMed ID: 31820484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.
    Watson GS; Craft S
    CNS Drugs; 2003; 17(1):27-45. PubMed ID: 12467491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
    Watson GS; Craft S
    J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and Alzheimer's Disease: A Link not as Simple as it Seems.
    Salas IH; De Strooper B
    Neurochem Res; 2019 Jun; 44(6):1271-1278. PubMed ID: 30523576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder.
    Kshirsagar V; Thingore C; Juvekar A
    Metab Brain Dis; 2021 Jan; 36(1):67-83. PubMed ID: 32986168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.